Page results
-
At University College London Hospitals NHS Foundation Trust (UCLH) we value our reputation for top quality care and financial probity and conduct our business in an ethical manner.
-
One of our patients who is recovering from COVID-19 has been appearing across national media as she recounts her story and thanks the staff who saved her life.
-
UCLH has recruited the first patient to a global study of a new drug in early development, called NI0752, which is thought to reduce the production of a protein in the brain called tau.
-
This information is for patients receiving steroids for immunotherapy toxicity.
-
This page is for cancer patients receiving immunotherapy treatment.
-
Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.
-
A new surgical technique could remove the risk of urinary incontinence after surgery to remove the prostate for men with prostate cancer.
-
This page explains what sperm banking is, how it works and how it can benefit you.
-
A UCLH rheumatology team is leading an exciting project to help understand the reasons for young people missing their hospital appointments and find ways to improve this.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
File results
-
FOI/2021/0345 - Maternity unit closures
-
FOI/2021/0349 - Cancer treatment
-
FOI/2021/0351 - Patients brought to A&E presenting complaint related to mental health
-
FOI/2021/0353 - Operational Pressures Escalation Levels (OPEL) Policy
-
FOI/2021/0363 - Robot assisted laparascopic prostatectomy cost
-
FOI/2021/0367 - Religious accommodation
-
FOI/2021/0369 - Telecommunications
-
FOI/2021/0377 - Stonewall diversity applications
-
FOI/2021/0381 - International nursing agency spend
-
FOI/2021/0388 - Digital dictation/ Voice recognition system